InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Vivo Capital IX, LLC. Insider active across 2 companies, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 6 reports have been logged. Breakdown: 1 buy · 4 sells. Total volume traded: €3.9m. Activity tracked since 23 June 2021. The latest transaction was filed on 5 May 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Vivo Capital IX, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
3,157,894 shares@ €1.7308100.0% of flowCommon StockSEC:0001213900-23-065297:0
Canonical exit: 7 Nov 2023 (T+90)
5,374 shares@ US$12.251.6% of flowCommon StockSEC:0001213900-22-024317:0
41,800 shares@ US$15.1915.5% of flowCommon StockSEC:0001213900-22-024052:0
2,365,545 sharesCommon StockSEC:0001140361-21-037658:0
37,980 shares@ US$29.8024.3% of flowCommon StockSEC:0001213900-21-034310:0
91,620 shares@ US$29.7058.6% of flowCommon StockSEC:0001213900-21-034298:0
6 of 6 declarations
About Vivo Capital IX, LLC
Vivo Capital IX, LLC is a director and insider at Tarsus Pharmaceuticals, Inc. and IO Biotech, Inc.
